In vitro assessment of new embolic liquids prepared from preformed polymers and water-miscible solvents for aneurysm treatment

Biomaterials

Volumn 21, Issue 8, 2000, Pages 803-811

  Mottu, F ^a   Gailloud, P ^a   Massuelle, D ^a   Rufenacht D A ^a   Doelker, E ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Aneurysms; Embolic liquids; Preformed polymers; Solubility parameters; Toxicity; Water miscible solvents

Indexed keywords

BIOCOMPATIBILITY; NEUROPHYSIOLOGY; PATIENT TREATMENT; PH EFFECTS; PHOSPHATES; PHYSIOLOGICAL MODELS; PRECIPITATION (CHEMICAL); SOLUBILITY; SOLVENTS; TOXICITY; WATER;

BISMUTH OXIDE; CEREBRAL ANEURYSM; EMBOLIC LIQUIDS; RADIOPAQUE AGENTS;

BIOMATERIALS;

1 METHYL 2 PYRROLIDINONE; 4 HYDROXYMETHYL 2,2 DIMETHYL 1,3 DIOXOLANE; ACETONE; ALCOHOL; BISMUTH DERIVATIVE; BUFFER; CELLULOSE ACETATE; DIGLYME; DIMETHYL ISOSORBIDE; DIMETHYL SULFOXIDE; ETHYLENE GLYCOL DIMETHYL ETHER; GLYCEROL FORMAL; GLYCOFUROL; LACTIC ACID ETHYL ESTER; MACROGOL 200; MOWILITH 60; MOWILITH DS; PARALOID K120N; POLY(BUTYL METHACRYLATE0; POLY(ETHYL ACRYLATE CO METHYL METHACRYLATE); POLY(ETHYL METHACRYLATE); POLY(METHYL METHACRYLATE); POLYACRYLONITRILE; POLYMER; POLYVINYL ACETATE; POLYVINYL BUTYRATE; POLYVINYL FORMAL; POLYVINYLCHLORIDE; PROPYLENE GLYCOL; SOLVENT; TETRAHYDROFURYL ALCOHOL; UNCLASSIFIED DRUG; WATER;

ANGIOGRAPHY; BIOCOMPATIBILITY; BRAIN ARTERY ANEURYSM; DRUG MIXTURE; DRUG STABILITY; IN VITRO STUDY; MODEL; POLYMERIZATION; PRIORITY JOURNAL; REVIEW; SOLUBILIZATION; TECHNIQUE; VISCOSITY;

ANGIOGRAPHY, DIGITAL SUBTRACTION; BIOCOMPATIBLE MATERIALS; EMBOLIZATION, THERAPEUTIC; HUMANS; INTRACRANIAL ANEURYSM; MATERIALS TESTING; MODELS, ANATOMIC; POLYMERS; SOLUBILITY; SOLVENTS; VISCOSITY; WATER;

EID: 0034001542     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0142-9612(99)00243-4     Document Type: Article

References (61)

1. Serbinenko F.A. Balloon catheterization and occlusion of major cerebral vessels. J Neurosurg. 41:1974;125-145.
2. Debrun G., Lacour P., Caron J.-P., Hurth M., Comoy J., Keravel Y. Detachable balloon and calibrated-leak balloon techniques in the treatment of cerebral vascular lesions. J Neurosurg. 49:1978;635-649.
3. Hilal S.K. Synthetic fiber coated platinum coils successfully used for the endovascular treatment of arteriovenous malformations, aneurysms and direct arteriovenous fistulae of the central nervous system. Radiology. 169(Suppl.):1988;28-29.
4. Mottu F., Rüfenacht D.A., Doelker E. Radiopaque polymeric materials for medical applications: current aspects of biomaterials research. Invest Radiol. 34:1999;323-335.
5. Mandai S., Kinugasa K., Ohmoto T. Direct thrombosis of aneurysms with cellulose acetate polymer. Part I. results of thrombosis in experimental aneurysms J Neurosurg. 77:1992;497-500.
6. Kinugasa K., Mandai S., Terai Y.et al. Direct thrombosis of aneurysms with cellulose acetate polymer. Part II. preliminary clinical experience J Neurosurg. 77:1992;501-507.
7. Park JB, Lakes RS, Polymeric implant materials. In: Biomaterials. An introduction. New York: Plenum Press, 1992. p. 141-68.
8. Chaloupka J.C., Vinuela F., Vinters H.V., Robert J. Technical feasibility and histopathologic studies of ethylene vinyl copolymer (EVAL) using a swine endovascular embolization model. Am J Neuroradiol. 15:1994;1107-1115.
9. Tsuruda J., James H.E., Camp P.E., Werner R. Acute dimethyl sulfoxide therapy in experimental brain edema. Part II. effect of dose and concentration on intracranial pressure, blood pressure, and central venous pressure Neurosurgery. 10:1982;355-359.
10. Marshall L.F., Camp P.E., Bowers S.A. Dimethyl sulfoxide for the treatment of intracranial hypertension: a preliminary trial. Neurosurgery. 14:1984;659-663.
11. De la Torre J.C., Kawanaga H.M., Rowed D.W.et al. Dimethyl sulfoxide in central nervous system trauma. Ann NY Acad Sci. 243:1975;362-389.
12. De la Torre J.C., Johnson C.M., Goode D.J., Mullan S. Pharmacologic treatment and evaluation of permanent experimental spinal cord trauma. Neurology. 25:1975;508-514.
13. Brown F.D., Johns L.M., Mullan S.M. Dimethyl sulfoxide in experimental brain injury, with comparison to mannitol. J Neurosurg. 53:1980;58-62.
14. Evans S, Perl J, Greff RJ. Method for embolizing blood vessels. US Patent 5,702,361; 1997.
15. Greff RJ, Jones ML, Evans S. Cellulose diacetate compositions for use in embolizing blood vessels. US Patent 5,580,568; 1996.
16. Shively M.L., Coonts B.A., Renner W.D., Southard J.L., Bennett A.T. Physico-chemical charcterization of a polymeric injectable implant delivery system. J Control Rel. 33:1995;237-243.
17. Taki W., Yonekawa Y., Iwata H., Uno A., Yamashita K., Amemiya H. A new liquid material for embolization of arteriovenous malformations. Am J Neuroradiol. 11:1990;163-168.
18. Terada T., Nakamura Y., Nakai K.et al. Embolization of arteriovenous malformations with peripheral aneurysms using ethylene vinyl alcohol copolymer. J Neurosurg. 75:1991;655-660.
19. Dunn R.L., Jeffers S.A., Holland K.M.et al. An in-situ forming biodegradable implant system for intratumoral delivery of cisplatin. Proc Int Symp Control Rel Biact Mater. 24:1997;163-164.
20. TM injectable implant system. Proc Int Symp Control Rel Biact Mater. 20:1993;458-459.
21. Joshi R., Himmelstein K.J. An in situ gelling system for parenteral delivery of macromolecular drugs. Proc Int Symp Control Rel Biact Mater. 24:1997;941-942.
22. Eliaz R.E., Wallach D., Kost J. The controlled release of soluble forms of tumor necrosis factor from injectable implant system. Proc Int Symp Control Rel Biact Mater. 24:1997;55-56.
23. Wang Y.-C.J., Kowal R.R. Review of excipients and pH’s for parenteral products used in the United States. J Parent Drug Assoc. 34:1990;452-462.
24. Smith DA, Tipton AJ. A novel parenteral delivery system. Proc 7270, AAPS 1996.
25. Spiegel A.J., Noseworthy M.M. Use of nonaqueous solvents in parenteral products. J Pharm Sci. 52:1963;917-927.
26. Driscoll C.D., Valentine R., Staples R.E., Chromey N.C., Kennedy G.L. Jr. Developmental toxicity of diglyme by inhalation in the rat. Drug Chem Toxicol. 21:1998;119-136.
27. Price C.J., Kimmel C.A., George J.D., Marr M.C. The developmental toxicity of diethylene glycol dimethyl ether in mice. Fundam Appl Toxicol. 8:1987;115-126.
28. 'Arasolve' DMI: dimethyl isosorbide; ICI Technical Note; 1995.
29. Eckenfels A., Kruss B., Kuritsch W. Zur tierexperimentellen Prüfung von InjecktionslÖsungen auf intraarterielle Verträglichkeit. Arzneim Forsch/Drug Res. 34:1984;15-20.
30. Dresser T.H., Rivera E.R., Hoffmann F.J., Finch R.A. Teratogenic assessment of four solvents using the frog embryo teratogenesis assay-Xenopus (FETAX). J Appl Toxicol. 12:1992;49-56.
31. Brazeau G.A., Fung H.L. Use of an in vitro model for the assessment of muscle damage from intramuscular injections: in vitro-in vivo correlation and predictability with mixed solvent systems. Pharm Res. 6:1989;766-771.
32. Heintz C., Boymond C. Aspects pharmaco-toxicologiques et utilisation thérapeutique de quelques solvants injectables non aqueux miscibles à l'eau. STP Pharma. 5:1989;548-560.
33. Montaguti P., Melloni E., Cavalletti E. Acute intravenous toxicity of dimethyl sulfoxide, polyethylene glycol 400, dimethylformamide, absolute ethanol, and benzyl alcohol in inbred mouse strains. Drug Res. 44:1994;566-570.
34. Sampei K., Hashimoto N., Tsukahara T., Kazekawa K., Iwata H., Takaichi S. Histological changes in brain tissue and vasculature after intracarotid infusion of organic solvents in rats. Neuroradiology. 38:1996;291-294.
35. Carricaburu P., Lacroix R., Lacroix J. Modifications de l'électrorétinogramme de la souris blanche après administration parentérale de solvants organiques. Ann Pharm Fr. 38:1980;155-160.
36. Kassell N.F., Sprowell J.A., Boarini D.J., Olin J.J. Effect of dimethyl sulfoxide on the cerebral and systemic circulations of the dog. Neurosurgery. 12:1983;24-28.
37. Becci P.J., Knickerbocker M.J., Reagan E.L., Parent R.A., Burnette L.W. Teratogenicity study of N-methylpyrrolidone after dermal applications to Sprague-Dawley rats. Fundam Appl Toxicol. 2:1982;73-76.
38. Lee K.P., Chromey N.C., Culik R., Barnes J.R., Schneider P.W. Toxicity of N-methyl-2-pyrrolidone (NMP): teratogenic, subchronic, and two-year inhalation studies. Fundam Appl Toxicol. 9:1987;222-235.
39. Cheav S.L., Salloum S., Foussard-Blanpin O. Etude toxico-pharmacologique du glycérolformal. Ann Pharm Fr. 44:1986;293-300.
40. Cheav S.L., Salloum S., Pieri F., Kirkiacharian S. Action du glycérolformal sur le système cardiovasculaire. Ann Pharm Fr. 43:1985;491-503.
41. Anderson D., McGregor D.B. The effect of solvents upon the yield of revertants in the Salmonella/activation mutagenicity assay. Carcinogenesis. 1:1980;363-366.
42. Mayer V.W., Goin C.J., Taylor-Mayer R.E. Aneuploidy induction in Saccharomyces cerevisiae by two solvent compounds, 1-methyl-2-pyrrolidone and 2-pyrrolidinone. Environ Mol Mutagen. 11:1988;31-40.
43. Mori Y., Yamazaki H., Toyoshi K.et al. Inhibitory effect of organic solvents on the mutagenicity of N-nitrosodialkylamines in Salmonella. Mutat Res. 142:1985;153-158.
44. Zimmermann F.K., Holzwarth U.L.I., Scheel I., Resnick M.A. Aprotic polar solvents that affect porcine brain tubulin aggregation in vitro induce aneuploidy in yeast cells growing at low temperatures. Mutat Res. 201:1988;431-442.
45. Wells D.A., Thomas H.F., Digenis G.A. Mutagenicity and cytotoxicity of N-methyl-2-pyrrolidone and 4-(methylamino)butanoic acid in the Salmonella/microsome assay. J Appl Toxicol. 8:1988;135-139.
46. Engelhardt G., Fleig H. 1-methyl-2-pyrrolidone (NMP) does not induce structural and numerical chromosomal aberrations in vivo. Mutat Res. 298:1993;149-155.
47. Hildebrand J.H., Scott R.L. Evaluation of solubility parameters. The Solubility of Nonelectrolytes. 1950;424-439 Reinhold Publishing Corporation, New York.
48. Hansen C.M. The universality of the solubility parameter. Ind Eng Chem Prod Res Dev. 8(3):1969;2-11.
49. Rowe R.C. Binder-substrate interactions in tablets: a theoretical approach based on solubility parameters. Acta Pharm Technol. 34:1988;144-146.
50. Barton A.F.M. Handbook of solubility parameters and other cohesion parameters. 1991;CRC Press, Boca Raton.
51. Fuchs O. Solvents and non-solvents for polymers. Brandrup J., Immergut E.H. Polymer handbook. 1989;379-407 Wiley-Interscience, New York.
52. Akimova AY, Buyanov VM, Galperin EI, Davydov AB, Egiev VN, Kremli SM, Kuzovlev NF, Lukyanova NA, Timokhina VI. Composé pour l'occlusion des conduits et des cavités dans l'organisme. French Patent 2,610,828; 1988.
53. R. Invest Radiol. 19:1984;36-44.
54. Taki W., Nishi S., Yamashita K.et al. Selection and combination of various ensovascular techniques in the treatment of giant aneurysms. J Neurosurg. 77:1992;37-42.
55. Hoy K.L. Solubility parameter as a design parameter for water borne polymers and coatings. J Coat Fab. 19:1989;53-67.
56. Gailloud P., Pray J.R., Muster M., Piotin M., Fasel J.H.D., Rüfenacht D.A. An in vitro anatomic model of the human cerebral arteries with saccular arterial aneurysms. Surg Radiol Anat. 19:1997;119-121.
57. Florence A.T., Attwood D. Surfactants. Physicochemical principles of pharmacy. 1988;173-227 MacMillian Press, London.
58. Feldman S., Gibaldi M. Effect of urea on solubility. Role of water structure. J Pharm Sci. 56:1967;370-375.
59. Van Krevelen D.W. Properties of polymers: their correlation with chemical structure; their numerical estimation and prediction from additive group contributions. 1990;Elsevier, Amsterdam.
60. Chaloupka JC, Guglielmi G, Vinuela F. Direct thrombosis of aneurysms. J Neurosurg 1993;78:1006-8 (letter).
61. Laurent A, Wassef M, Zhang HQ, et al. Solutions gélifiantes pour embolisation: étude animale de la toxicité cardiovasculaire d’un constituant, le diméthylsulfoxyde. Neuroradiol 1997;24:314.